Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

Authors

Lone Simonsen, George Washington UniversityFollow
Robert J. Taylor, Sage Analytica, Bethesda, United States
Cynthia Schuck-Paim, Sage Analytica, Bethesda, United States
Roger Lustig, Sage Analytica, Bethesda, United States
Michael J. Haber, Rollins School of Public Health, Atlanta, United States
K. P. Klugman, Emory University School of Medicine

Document Type

Journal Article

Publication Date

2014

Journal

The Lancet Respiratory Medicine

Volume

Volume 2, Issue 5

Inclusive Pages

387-394

APA Citation

Simonsen, L., Taylor, R. J., Schuck-Paim, C., Lustig, R., Haber, M., & Klugman, K. P. (2014). Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: A time series analysis. The Lancet Respiratory Medicine, 2(5), 387-394.

Peer Reviewed

1